Sarcopenia and high NLR are associated with the development of hyperprogressive disease after second‐line pembrolizumab in patients with non‐small‐cell lung cancer
Petrova, M. P., Donev, I. S., Radanova, M. A., Eneva, M. I., Dimitrova, E. G., Valchev, G. N., Minchev, V. T., Taushanova, M. S., Boneva, M. V., Karanikolova, T. S., Gencheva, R. B., Zhbantov, G. A., Ivanova, A. I., Timcheva, C. V., P.Pavlov, B., Megdanova, V. G., Robev, B. S., Conev, N. V.
Published in Clinical and experimental immunology (01.12.2020)
Published in Clinical and experimental immunology (01.12.2020)
Get full text
Journal Article
Prevalence and prognosis of PIK3CA mutations in Bulgarian patients with metastatic breast cancer receiving endocrine therapy in first‐line setting
Gencheva, R., Petrova, M., Kraleva, P., Hadjidekova, S., Radanova, M., Conev, N., Stoyanov, D., Arabadjiev, J., Tazimova, E., Bachurska, S., Eneva, M., Tsvetkova, M., Zhbantov, G., Karanikolova, T., Manov, D., Ivanova, A., Taushanova‐Hadjieva, M., Staneva, R., Dimitrova, E., Donev, I.
Published in Cancer reports (01.02.2024)
Published in Cancer reports (01.02.2024)
Get full text
Journal Article